Two Sigma Advisers »

Celldex Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $604k 14k 41.97
2023-03-31 $1.3M 36k 35.98
2022-12-31 $3.0M 67k 44.57
2022-09-30 $3.4M 120k 28.11
2022-06-30 $6.2M 230k 26.96
2022-03-31 $5.2M 154k 34.06
2021-12-31 $2.3M 60k 38.64
2021-06-30 $2.9M 88k 33.44
2021-03-31 $4.3M 210k 20.60
2020-12-31 $7.0M 402k 17.52
2020-09-30 $6.6M 443k 14.83
2020-06-30 $729k 56k 13.00
2019-12-31 $37k 17k 2.24
2019-09-30 $43k 20k 2.11
2019-06-30 $72k 27k 2.67
2019-03-31 $147k 30k 4.92